Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "CRDMO"

72 News Found

CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force
People | June 04, 2026

CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force

Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector


Aurigene bets big on CRDMO expansion with $100 million outlay
News | April 28, 2026

Aurigene bets big on CRDMO expansion with $100 million outlay

Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities


WuXi Biologics teams up with Qatar Free Zones Authority to launch first Middle East CRDMO Centre
R&D | December 09, 2025

WuXi Biologics teams up with Qatar Free Zones Authority to launch first Middle East CRDMO Centre

This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region


Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO
People | July 28, 2025

Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO

His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited


India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
News | February 26, 2025

India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain


WuXi Biologics breaks ground on CRDMO Center in Singapore
News | March 28, 2024

WuXi Biologics breaks ground on CRDMO Center in Singapore

The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO
People | June 15, 2026

Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO

Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy


Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey
News | June 11, 2026

Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey

Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials